Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP798754.RAsN7Q7NLV9--l7Vo1Q9f-fGD9_XPAOJTTFouJk1evTj4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP798754.RAsN7Q7NLV9--l7Vo1Q9f-fGD9_XPAOJTTFouJk1evTj4130_assertion type Assertion NP798754.RAsN7Q7NLV9--l7Vo1Q9f-fGD9_XPAOJTTFouJk1evTj4130_head.
- NP798754.RAsN7Q7NLV9--l7Vo1Q9f-fGD9_XPAOJTTFouJk1evTj4130_assertion description "[Furthermore, human AFAR1 catalyses the rate limiting step in the synthesis of the neuromodulator gamma-hydroxybutyrate (GHB) and was found elevated in neurodegenerative diseases such as Alzheimer's and dementia with Lewy bodies (DLB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP798754.RAsN7Q7NLV9--l7Vo1Q9f-fGD9_XPAOJTTFouJk1evTj4130_provenance.
- NP798754.RAsN7Q7NLV9--l7Vo1Q9f-fGD9_XPAOJTTFouJk1evTj4130_assertion evidence source_evidence_literature NP798754.RAsN7Q7NLV9--l7Vo1Q9f-fGD9_XPAOJTTFouJk1evTj4130_provenance.
- NP798754.RAsN7Q7NLV9--l7Vo1Q9f-fGD9_XPAOJTTFouJk1evTj4130_assertion SIO_000772 18752886 NP798754.RAsN7Q7NLV9--l7Vo1Q9f-fGD9_XPAOJTTFouJk1evTj4130_provenance.
- NP798754.RAsN7Q7NLV9--l7Vo1Q9f-fGD9_XPAOJTTFouJk1evTj4130_assertion wasDerivedFrom befree-20150227 NP798754.RAsN7Q7NLV9--l7Vo1Q9f-fGD9_XPAOJTTFouJk1evTj4130_provenance.
- NP798754.RAsN7Q7NLV9--l7Vo1Q9f-fGD9_XPAOJTTFouJk1evTj4130_assertion wasGeneratedBy ECO_0000203 NP798754.RAsN7Q7NLV9--l7Vo1Q9f-fGD9_XPAOJTTFouJk1evTj4130_provenance.